Header Logo

IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability.

Wallace AL, Schneider MI, Toomey JR, Schneider RM, Klempner MS, Wang Y, Cavacini LA. IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability. Vaccine. 2020 11 03; 38(47):7490-7497.

View in: PubMed